Caveolae Mediated Bacterial Uptake in the Urinary Tract

小凹介导的尿道细菌摄取

基本信息

  • 批准号:
    7440175
  • 负责人:
  • 金额:
    $ 37.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-07-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Uropathogenic E.coli (UPEC) account for over 80% of urinary tract infections (UTIs). It is now known invasion of the bladder epithelial cells (BECs) is a critical initiating step in UTIs. We have demonstrated that UPEC invasion is localized to distinct cellular entities in the BEG membrane loosely- termed caveolae. These caveolae are comprised of lateral assemblies of cholesterol, lipids and select proteins such as caveolin-1. We hypothesized that the entry of UPEC into BECs is a highly dynamic event and therefore the host-cell proteins that mediate bacterial entry could be proteins that are selectively recruited to caveolae or become activated within these microdomains following exposure to UPEC. Our initial studies have revealed that two proteins, flotillin-1 and annexin-ll, were recruited to caveolae whereas the third, caveolin-1, became tyrosine-phosphorylated following exposure to UPEC. Another finding emerging from proteome analysis of BECs is that a significant proportion of the proteins identified as caveolar components are known to be regulated by cAMP, a major second messenger implicated in regulating luminal surface area of the bladder by triggering endo- and exocytosis of BEG vesicles which serve as repositories of luminal membranes. This finding, revealed possible parallels between caveolae mediated bacterial entry nto BECs and regular endocytosis of luminal membrane by BECs following voiding of urine. The goal of this research proposal is to extend and expand this line of investigation. Therefore, we propose to: ) Elucidate the mechanism by which flotillin-1, annexin-ll, and caveolin-1 contribute to bacterial entry into 3ECs. (2) Use proteome mining approaches to extend the identification of caveolar components essential for UPEC invasion of BECs.(3) Investigate the regulatory role of cAMP on UPEC invasion of BECs and the mpact of modulators of intracellular cAMP in conferring protection against experimental UTIs. We believe that a systematic approach to the identification of caveolar determinants of bacterial entry will provide a comprehensive picture of the dynamic molecular interactions occurring in the invasion process and also yield candidate proteins that could potentially serve as targets for drug therapy.
描述(申请人提供):泌尿系致病性大肠埃希菌(UPEC)占尿路感染(UTIs)的80%以上。目前已知,膀胱上皮细胞(BECs)的侵袭是尿路感染发生的关键步骤。我们已经证明,UPEC的侵袭局限于BEG膜上不同的细胞实体,宽泛地称为小凹。这些小窝由胆固醇、脂类和精选蛋白质组成,如小窝蛋白-1。我们假设UPEC进入BECs是一个高度动态的事件,因此介导细菌进入的宿主细胞蛋白可能是选择性地招募到小窝中的蛋白质,或者在接触UPEC后在这些微域中被激活。我们的初步研究表明,两种蛋白质,Flotillin-1和Annexin-11,被招募到小窝中,而第三种蛋白质,小窝蛋白-1,在暴露于UPEC后发生酪氨酸磷酸化。从对BEC的蛋白质组分析中发现的另一个发现是,已知相当大比例的空泡成分受cAMP调节,cAMP是一种主要的第二信使,通过触发作为腔膜储存库的BEG囊泡的内吞和胞吐来调节膀胱腔表面积。这一发现揭示了小窝介导的细菌进入BECs和BECs排尿后对腔膜的规律性内吞作用之间可能的相似之处。这项研究建议的目标是延伸和扩大这一调查路线。因此,我们建议:)阐明Flotillin-1、Annexin-11和Caveolin-1促进细菌进入3EC的机制。(2)利用蛋白质组挖掘技术扩大对UPEC侵袭BECs所必需的空泡成分的鉴定。(3)研究cAMP对UPEC侵袭BECs的调节作用,以及细胞内cAMP调节剂在抗实验性UTIs中的作用。我们相信,识别细菌进入的空泡决定因素的系统方法将提供在入侵过程中发生的动态分子相互作用的全面图景,并产生可能作为药物治疗靶点的候选蛋白质。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Soman N Abraham其他文献

Soman N Abraham的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Soman N Abraham', 18)}}的其他基金

A novel vaccination strategy to curb recUTIs
遏制复发尿路感染的新型疫苗接种策略
  • 批准号:
    10665990
  • 财政年份:
    2023
  • 资助金额:
    $ 37.15万
  • 项目类别:
Platelet- mast cell interactions as determinants of the vascular pathology in septic shock.
血小板-肥大细胞相互作用作为败血性休克血管病理学的决定因素。
  • 批准号:
    10343476
  • 财政年份:
    2021
  • 资助金额:
    $ 37.15万
  • 项目类别:
Loss of Bladder Control Following Recurrent Infections
反复感染后膀胱失去控制
  • 批准号:
    10368136
  • 财政年份:
    2020
  • 资助金额:
    $ 37.15万
  • 项目类别:
Loss of Bladder Control Following Recurrent Infections
反复感染后膀胱失去控制
  • 批准号:
    10612716
  • 财政年份:
    2020
  • 资助金额:
    $ 37.15万
  • 项目类别:
Immunotherapy to combat skin infections
免疫疗法对抗皮肤感染
  • 批准号:
    9906450
  • 财政年份:
    2019
  • 资助金额:
    $ 37.15万
  • 项目类别:
Aberrant remodeling of bladder following infection
感染后膀胱异常重塑
  • 批准号:
    10381529
  • 财政年份:
    2019
  • 资助金额:
    $ 37.15万
  • 项目类别:
Immune mediated exocytosis of intravesicular UPEC from bladder cells
免疫介导的膀胱细胞囊内 UPEC 胞吐作用
  • 批准号:
    8668381
  • 财政年份:
    2014
  • 资助金额:
    $ 37.15万
  • 项目类别:
Immune mediated exocytosis of intravesicular UPEC from bladder cells
免疫介导的膀胱细胞囊内 UPEC 胞吐作用
  • 批准号:
    8908009
  • 财政年份:
    2014
  • 资助金额:
    $ 37.15万
  • 项目类别:
Immune mediated exocytosis of intravesicular UPEC from bladder cells
免疫介导的膀胱细胞囊内 UPEC 胞吐作用
  • 批准号:
    9043871
  • 财政年份:
    2014
  • 资助金额:
    $ 37.15万
  • 项目类别:
Immune mediated exocytosis of intravesicular UPEC from bladder cells
免疫介导的膀胱细胞囊内 UPEC 胞吐作用
  • 批准号:
    9265085
  • 财政年份:
    2014
  • 资助金额:
    $ 37.15万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 37.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了